> 本文内容由[CXCL10](https://zh.wikipedia.org/wiki/CXCL10)转换而来。


**CXCL10**（）是一小分子的[细胞因子](../Page/细胞因子.md "wikilink")属于CXC[趋化因子](../Page/趋化因子.md "wikilink")家族\[1\]，又被称作“干扰素伽玛诱导的10千道尔顿蛋白”（10 kDa interferon-gamma-induced protein，IP-10）\[2\] 。[干扰素伽玛](../Page/干扰素伽玛.md "wikilink")可以在多种细胞（如[巨噬细胞](../Page/巨噬细胞.md "wikilink")\[3\] ，[单核细胞](https://zh.wikipedia.org/wiki/单核细胞 "wikilink")\[4\] ，[内皮细胞](https://zh.wikipedia.org/wiki/内皮细胞 "wikilink")\[5\]和[成纤维细胞](../Page/成纤维细胞.md "wikilink")）中诱导CXCL10的表达。CXCL10的功能包括对[T细胞](../Page/T细胞.md "wikilink")和单核细胞的细胞趋化作用\[6\]\[7\]，促进T细胞黏附于内皮细胞\[8\]，抗[肿瘤](https://zh.wikipedia.org/wiki/肿瘤 "wikilink")\[9\]，及[新血管形成](https://zh.wikipedia.org/wiki/新血管形成 "wikilink")\[10\]。人类的CXCL10基因与[CXCL9](../Page/CXCL9.md "wikilink")，[CXCL11](../Page/CXCL11.md "wikilink")的基因相邻聚集在第四染色体上。CXCL10, CXCL9和CXCL11结合[趋化因子受体](https://zh.wikipedia.org/wiki/趋化因子受体 "wikilink")[CXCR3](../Page/CXCR3.md "wikilink")而起其细胞趋化作用\[11\]\[12\] 。

## 参见

  - [趋化因子](../Page/趋化因子.md "wikilink")
  - [CXCR3](../Page/CXCR3.md "wikilink")
  - [CXCL9](../Page/CXCL9.md "wikilink")
  - [CXCL11](../Page/CXCL11.md "wikilink")

## 参考文献

<div class="references-small">

<references />

</div>

## 外部链接

  - [Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006 Feb 9;354(6):610-21.](http://content.nejm.org/cgi/content/extract/354/6/610)

[Category:细胞因子](https://zh.wikipedia.org/wiki/Category:细胞因子 "wikilink") [Category:免疫学](https://zh.wikipedia.org/wiki/Category:免疫学 "wikilink")

1.  Liu L, Callahan MK, Huang D, Ransohoff RM. Chemokine receptor CXCR3: an unexpected enigma. Curr Top Dev Biol. 2005;68:149-81.
2.  Kaplan G, Luster AD, Hancock G, Cohn ZA. The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med. 1987 Oct 1;166(4):1098-108.
3.  Narumi S, Hamilton TA. Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity. J Immunol. 1991 May 1;146(9):3038-44.
4.  Narumi S, Hamilton TA. Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity. J Immunol. 1991 May 1;146(9):3038-44.
5.  Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med. 1995 Jul 1;182(1):155-62.
6.  Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med. 1996 Sep 1;184(3):963-9.
7.  Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL, Gould SL, Springer MS, DeMartino JA. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem. 1998 Jul 17;273(29):18288-91.
8.  Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med. 1995 Jul 1;182(1):155-62.
9.  Luster AD, Leder P. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J Exp Med. 1993 Sep 1;178(3):1057-65
10. Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med. 1995 Jul 1;182(1):155-62.
11. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med. 1996 Sep 1;184(3):963-9.
12. Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL, Gould SL, Springer MS, DeMartino JA. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem. 1998 Jul 17;273(29):18288-91.